In Brief: PolyMedica
This article was originally published in The Tan Sheet
Executive Summary
PolyMedica: Expands distribution of Azo-Cranberry supplement to the U.K. under an agreement with Boots retail drug chain, the Woburn, Mass.-based firm reports Aug. 28. Bolstered by the Boots relationship, further expansion into both European and other international markets is expected, PolyMedica says. Azo-Cranberry was launched in the U.S. in early 1995 ("The Tan Sheet" May 15, 1995, p. 5). The product, a cranberry juice concentrate in capsule form marketed for relief of urinary tract discomfort, currently is sold in U.S. chain drug and food retailers, including Eckerd, Big B, FoxMeyer, McKesson and Bergen Brunswig...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning